6533b834fe1ef96bd129ccf5
RESEARCH PRODUCT
Detection of Cancer Stem Cells Using AC133 Antibody
Antonina BenfantePietro MancusoVeronica CatalanoGiorgio StassiFrancesco DieliMatilde Todarosubject
Alternative methodseducation.field_of_studyChemotherapybiologymedicine.medical_treatmentPopulationCancermedicine.diseaseStem cell markerExpression patternCancer stem cellbiology.proteinmedicineCancer researchAntibodyeducationdescription
The cancer stem cell (CSC) model postulates that tumors are formed and maintained by a small population of undifferentiated cells, characterized by unique self-renewal properties and malignant potential. As CSCs survive chemotherapy inducing tumor recurrence, the specific targeting and eradication of these cells represents an important therapeutic challenge in cancer cure. Recent findings on CD133, a pentaspan transmembrane glycoprotein, discuss its application in the identification and isolation of SCs from cancerous tissues. However, the appropriateness of this protein constitutes an ongoing discussion. The expression pattern is debated and several issues highlight the need for additional surface molecules or alternative methods to identify tumor-initiating cells. In this chapter, we will critically summarize progresses and concerns for targeting CSCs via this marker.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2012-01-01 |